AGI Therapeutics Limited

Patent Applications and Registrations

Patent applications and USPTO patent grants for AGI Therapeutics Limited.The latest application filed is for "methods and compositions comprising at least one alpha3 beta4 nachr antagonist or pharmaceutically acceptable salt thereof".

Company Profile

0.4.4

AGI Therapeutics Limited -
AGI Therapeutics Ltd. - Athlone IE
AGI Therapeutics Ltd. - Co Roscommon IE
AGI Therapeutics Limited - Roscommon IE
AGI Therapeutics, Ltd. - Dublin IE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
METHODS AND COMPOSITIONS COMPRISING AT LEAST ONE ALPHA3 BETA4 nAChR ANTAGONIST OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF App 20130030057 - Devane; John	2013-01-31
Formulations and methods of treating inflammatory bowel disease Grant 7,928,092 - Devane , et al. April 19, 2	2011-04-19
Formulations and Methods of Treating Inflammatory Bowel Disease App 20100278917 - Devane; John ; et al.	2010-11-04
Modified release formulations and methods of treating inflammatory bowel disease Grant 7,825,106 - Devane , et al. November 2, 2	2010-11-02
METHODS AND COMPOSITIONS COMPRISING AT LEAST ONE ALPHA3 BETA4 nAChR ANTAGONIST OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF App 20100196479 - Devane; John	2010-08-05
Formulations and methods of treating inflammatory bowel disease Grant 7,737,133 - Devane , et al. June 15, 2	2010-06-15
Proton pump inhibitor formulations, and methods of preparing and using such formulations App 20050232992 - Devane, John ; et al.	2005-10-20
Treatment of abnormal increases in gastrointestinal motility with (R)-verapamil Grant 6,849,661 - Kelly , et al. February 1, 2	2005-02-01

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.